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Release of drug substances suspended in non- 
aqueous media includes the following steps: 
a. transport of the solid to the oil/water inter- 
face; 
b. transport through this interface; 
c. dissolution in the aqueous phase. 
In the under-mentioned study the mechanisms 
involved in the release process were investi- 
gated in a model system, following a systematic 
approach. Sodium chloride, paracetamol and 
chloramphenicol, all almost insoluble in the 
non-polar medium (liquid paraffin), were 
chosen as model substances covering a wide 
range of water solubilities: 360, I3 and 3.6 
mg/ml respectively. Other parameters studied 
were particle size (5-60/~m), concentration of 
the solid (up to io% m/m) and the presence of 
additives in the liquid paraffin: DOSs-Na [di- 
(2-ethyl-hexyl) sodium sulphosuccinate], Span 
85 (sorbitan trioleate) and water. The release 
rate was determined by putting a suspension on 
top of a stirred aqueous layer. The interfacial 
area and the layer thickness were kept constant. 
For the sodium chloride suspensions the re- 
lease was controlled by transport to the inter- 
face, which means essentially sedimentation in 
the model system used. As agglomeration oc- 
curred during settling not only the primary 
particle size, but also the formation of ag- 
glomerates and therefore the concentration of 
the solid was important. Additives like DOSS- 
Na and water influenced the release by chang- 
ing the degree of agglomeration, Spafi 85 by 
decreasing the degree of wettability of the par- 
ticles. For paracetamol and chloramphenicol 
suspensions the particles stayed at the interface 
during dissolution. Sedimentation controlled 
the release only as long as the rate of transport 
to the interface did not exceed a certain value. 
After reaching this limiting rate the process be- 
came dissolution controlled. Then the release 
rate was constant and independent of particle 
size, concentration and degree of agglomer- 
ation. With the additives present in the non- 
polar phase the release mechanism could change, 
resulting in dramatic alterations in release 
profiles. 
The observed phenomena could be predicted 
to a large extent by analysing the different 
steps and applying existing theories on the 
stability of particles against agglomeration 
(OLVO-theory), the rate of agglomeration, the 
behaviour of particles at interfaces and the 
dissolution of solid particles. For these predic- 
tions only basic physico-chemical properties 
of the system invo lved -  which are available in 
the literature or can be measured rather easily 
- have to be known. 
The results obtained in the model system 
used are of importance to pharmacy as this 
system simulates in part the release of drugs 
from fatty suspension suppositories in vivo. But 
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as melting and spreading of the suppository are 
not taken into account these in vitro results 
cannot directly be extrapolated to the in vivo 
situation. 
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A frequently encountered speculation with re- 
gard to rectal absorption of drugs is that drugs 
will enter the general circulation without first 
passing through the liver. This assumption is 
based on the fact that in man the inferior, and 
probably also the middle rectal veins pass di- 
rectly into the inferior vena  cava.  However this 
anatomical situation is complicated by the fact 
that the rectal veins are connected with each 
other by anastomoses. In the literature exper- 
imental evidence concerning the bypass of the 
liver after rectal administration in humans and 
tats is scarce. Therefore investigations were 
i~erformed in male rats and healthy male vol- 
unteers with three high-clearance drugs (lido- 
,:aine, propranolol and salicylamide) to com- 
i~are their rectal systemic availability with oral 
tvailability. From the literature it is known that 
these drugs show a substantial 'first-pass' effect 
~n humans and rats. 
Because excipients used in the preparation 
,~f solid dosage forms can influence the sys- 
temic availability and absorption rate of drugs 
considerably, these influences were excluded as 
~nuch as possible by administering the test 
Irugs in aqueous solution. The assays of drugs 
n blood and plasma were carried out according 
,o newly developed procedures applying gas 
~'hromatography with capillary and micro- 
I~acked columns, nitrogen selective detection 
and a solid injection system. 
The lidocaine experiments with humans 
showed that the mean rectal systemic avail- 
ability was significantly higher than orally: 63% 
versus 3I% (whole blood) and 7I% versus 
34% (plasma). An equation was derived for the 
calculation of the fraction of the dose given 
rectally that bypasses the liver after absorption. 
This mean fraction is slightly more than half of 
the dose administered, assuming that the total 
dose is absorbed. Repeating the oral and rectal 
experiments in the same panel of volunteers 
showed that the mean rectal systemic avail- 
ability based on plasma concentrations was 
now 67% versus 27% orally. Intra-individual 
variability was rather small, indicating that oral 
and rectal bioavailability of lidocaine is quite 
reproducible in a certain individual. 
The systemic availability of two different 
rectal dosage forms (suppository and capsule) 
was determined also in human volunteers. The 
mean systemic availability of the suppository 
(Witepsol HI 5, lidocaine-HC1) was 49% and 
54% was found for the capsule (containing 
slow-release granules, lidocaine-HCl), when 
compared to the results obtained in the pre- 
vious investigation after intravenous adminis- 
tration. Although early defaecation occasion- 
ally caused a loss of still unabsorbed drug the 
results confirm the previous findings that rectal 
administration of lidocaine results in a higher 
systemic availability than oral administration. 
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